查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1252569

2023-2032 年全球除顫器市場 - 按產品、最終用途、全球預測

Defibrillators Market - By Product, End-use & Global Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 320 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於新興國家/地區對可穿戴除顫器的偏好和採用率不斷上升，預計除顫器的全球市場將從 2023 年到 2032 年實現強勁增長。

植入式心律轉復除顫器 (ICD) 技術的眾多創新有望改善除顫器的性能、功能和臨床結果。 此外，對除顫器的需求顯著增加，因為臨床試驗表明佩戴除顫器可以提高心臟驟停高風險人群的生存率。

由於手術設備的改進和各種產品創新，除顫器植入術已成為門診手術。 例如，2020 年 7 月，雅培（Abbott）實驗室的 Gallant 產品線獲得了 FDA 的批准，該產品線是一系列開創性的聯網起搏器和除顫器植入物。 這一監管批准使該公司能夠加強其創新技術管道，並有助於增加患者、護理提供者和醫生之間的互動。

除顫器市場按產品、最終用途和地區劃分。

按產品劃分，體外除顫器細分市場預計將在預測期內佔據重要的市場份額。 預計這種增長將受到越來越多地採用這些設備和技術改進的推動，這些技術改進使它們易於使用和自動化。 院外心臟驟停 (OHCA) 是發病率和死亡率的重要驅動因素，增加了消費者對設備的興趣。

就最終用途而言，估計門診手術中心市場在分析期間將顯著增長。 ICD 植入在門診手術診所中的應用顯著增加。 在這樣的醫療環境下，ICD 報銷政策的加強有望進一步增加該分部的收入。

按地區劃分，2022年北美除顫器市場份額將超過37%。 這是由於該地區用於研發創新技術的私人研究資金有所增加。 該地區主要市場進入者的主導地位、慢性心髒病患病率上升、政府支持措施和有利的報銷制度都有助於其市場主導地位。 此外，完善的醫療基礎設施和專業的醫務人員也是推動北美除顫器市場增長的因素。

內容

第 1 章研究方法和範圍

第 2 章執行摘要

第 3 章除顫器行業洞察

  • 行業情況
  • 影響行業的因素
    • 司機
      • 心髒病患病率上升
      • 技術進步和創新設備的引進
      • 提高社會認可度
      • 對可穿戴除顫器的需求不斷擴大
    • 行業潛在的風險和挑戰
      • 設備價格高
      • 產品召回
  • 增長分析
    • 按產品分類
    • 按最終用途
  • COVID-19 影響分析
  • 2022 年按地區劃分的價格分析
  • 監管狀況
    • 美國
    • 歐洲
  • 退款場景
    • 植入式心律轉復除顫器 (ICD)
    • 自動體外除顫器 (AED)
  • 技術概況
  • 管道產品
  • 顯示風景
    • 植入式心律轉復除顫器 (ICD)
    • 可穿戴式體外除顫器 (WCD)
  • 啟動場景
  • 波特分析
  • PESTEL 分析

第 4 章競爭格局，2021 年

  • 介紹
  • 2021 年公司矩陣分析
  • 2021 年版全球公司份額分析
  • 戰略儀表板，2021 年

第 5 章除顫器市場：按產品分類

  • 主要產品趨勢
  • 植入式心律轉復除顫器 (ICD)
    • 皮下植入式除顫器
    • 經靜脈植入式心律轉復除顫器
      • 單腔 ICD
      • 雙腔 ICD
  • 體外心臟復律除顫器
    • 手動體外除顫器
    • 自動體外除顫器
      • 半自動體外除顫器
      • 全自動體外除顫器
    • 可穿戴式體外除顫器

第 6 章除顫器市場：按最終用途分類

  • 主要的最終用戶趨勢
  • 醫院
  • 門診手術中心
  • 其他

第 7 章除顫器市場：按地區

  • 主要區域趨勢
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 意大利
    • 波蘭
    • 荷蘭
    • 瑞典
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 韓國
    • 印度尼西亞
    • 泰國
    • 馬來西亞
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 智利
    • 哥倫比亞
    • 秘魯
  • 多邊環境協定
    • 南非
    • 沙特阿拉伯
    • 阿聯酋
    • 以色列
    • 伊朗
    • 土耳其人

第八章公司簡介

  • Abbott Laboratories, Inc.
  • AMI Italia
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • CU Medical Systems Co. Ltd
  • Koninkilijke Philips N.V.
  • Medtronic plc
  • Meditech Equipment Co., Ltd（Meditech Group）
  • MicroPort Scientific Corporation
  • Mindray Medical International Limited
  • Nihon Kohden Corporation
  • BPL Medical Technologies Pvt Ltd
  • Schiller AG
  • Stryker Corporation
  • ZOLL Medical Corporation（Asahi Kasei Group）
簡介目錄
Product Code: 5495

Global Defibrillators Market is set to witness robust growth between 2023 to 2032, owing to the surging preference for wearable cardioverter defibrillators and their adoption in several emerging nations.

The performance of the device, the functions it offers, as well as the clinical results, are all projected to improve as a result of numerous technological innovations in implantable cardioverter defibrillator (ICD) technology. Moreover, the demand for defibrillators has significantly increased due to clinical trials demonstrating improved survival rates in people at greater risk of cardiac arrest who get defibrillators.

Defibrillator implantation has become an outpatient operation given the improvements in surgical equipment and different product innovations. For instance, in July 2020, Abbott Laboratories received an FDA approval for its Gallant product line, a breakthrough series of connected pacemakers as well as defibrillator implants. The regulatory approval enabled the company to strengthen its pipeline of innovative technologies, which also helped increase interaction between patients, care providers, and physicians.

The defibrillator market has been divided in terms of product, end-use, and region.

Based on product, the external cardioverter defibrillator segment is expected to garner a sizable market share through the forecast period. The growth is expected to be accelerated by the growing adoption of these devices, and technical improvements that are enabling easy use & automation. Out-of-hospital cardiac arrest (OHCA) is one of the important factors that contribute to the morbidity and mortality, as well as fueling consumer interest in the device.

With respect to end-use, the ambulatory surgical centers market is estimated to grow significantly over the analysis timeframe. ICD implantation procedures are seeing a noticeable increase in the ambulatory surgery clinics. The segment revenue will be further boosted by the increasing reimbursement policies for ICDs in these healthcare settings.

From the regional perspective, the North America defibrillator market held more than 37% business share in 2022 credited to the rise in private research funding for the research and development of innovative technologies across the region. The predominance of major market players, the rising rate of chronic cardiac illnesses, supportive government measures, and a favorable reimbursement system, all contribute to the region's dominant market position. Moreover, the availability of well-equipped healthcare infrastructure and professional medical staff is also set to foster North America defibrillators market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Industry coverage
  • 1.2 Market scope & definitions
  • 1.3 Base estimates & working
    • 1.3.1 Data collection
  • 1.4 Forecast parameters
  • 1.5 COVID-19 impact analysis at global level
  • 1.6 Data validation
  • 1.7 Data sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Defibrillators industry 360 degree synopsis, 2018-2032
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 End-use trends
    • 2.1.4 Regional trends

Chapter 3 Defibrillators Industry Insights

  • 3.1 Industry landscape
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of cardiac diseases
      • 3.2.1.2 Technological advancements and introduction of innovative devices
      • 3.2.1.3 Increasing public awareness
      • 3.2.1.4 Increasing demand for wearable cardioverter defibrillators
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of the devices
      • 3.2.2.2 Product recalls
  • 3.3 Growth potential analysis
    • 3.3.1 By product
    • 3.3.2 By end use
  • 3.4 COVID- 19 impact analysis
  • 3.5 Pricing analysis, by region, 2022
    • 3.5.1 North America
    • 3.5.2 Europe
    • 3.5.3 Asia Pacific
    • 3.5.4 Latin America
    • 3.5.5 MEA
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
  • 3.7 Reimbursement scenario
    • 3.7.1 Implantable cardioverter defibrillators (ICDs)
    • 3.7.2 Automatic External Defibrillators (AEDs)
  • 3.8 Technology landscape
  • 3.9 Pipeline products
  • 3.10 Indication landscape
    • 3.10.1 Implantable cardioverter defibrillators (ICDs)
    • 3.10.2 Wearable external cardioverter defibrillators (WCDs)
  • 3.11 Startup scenario
  • 3.12 Porter's analysis
  • 3.13 PESTEL analysis

Chapter 4 Competitive Landscape, 2021

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2021
  • 4.3 Global company market share analysis, 2021
  • 4.4 Strategy dashboard, 2021

Chapter 5 Defibrillators Market, By Product

  • 5.1 Key product trends
  • 5.2 Implantable Cardioverter Defibrillator (ICDs)
    • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.2 Market estimates and forecast, 2018 - 2032 (Units)
    • 5.2.3 Subcutaneous implantable cardioverter defibrillator
      • 5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.3.2 Market estimates and forecast, 2018 - 2032 (Units)
    • 5.2.4 Transvenous implantable cardioverter defibrillator
      • 5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.4.2 Market estimates and forecast, 2018 - 2032 (Units)
      • 5.2.4.3 Single-chamber ICDs
        • 5.2.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
        • 5.2.4.3.2 Market estimates and forecast, 2018 - 2032 (Units)
      • 5.2.4.4 Dual-chamber ICDs
        • 5.2.4.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
        • 5.2.4.4.2 Market estimates and forecast, 2018 - 2032 (Units)
  • 5.3 External cardioverter defibrillator
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.2 Market estimates and forecast, 2018 - 2032 (Units)
    • 5.3.3 Manual external defibrillator
        • 5.3.3.1.1 Market estimates and forecast, 2018 - 2032 (USD Million)
        • 5.3.3.1.2 Market estimates and forecast, 2018 - 2032 (Units)
    • 5.3.4 Automated external defibrillator
        • 5.3.4.1.1 Market estimates and forecast, 2018 - 2032 (USD Million)
        • 5.3.4.1.2 Market estimates and forecast, 2018 - 2032 (Units)
      • 5.3.4.2 Semi-automated external defibrillator
        • 5.3.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
        • 5.3.4.2.2 Market estimates and forecast, 2018 - 2032 (Units)
      • 5.3.4.3 Fully automated external defibrillator
        • 5.3.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
        • 5.3.4.3.2 Market estimates and forecast, 2018 - 2032 (Units)
    • 5.3.5 Wearable external cardioverter defibrillator
      • 5.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.3.5.2 Market estimates and forecast, 2018 - 2032 (Units)

Chapter 6 Defibrillators Market, By End-use

  • 6.1 Key end-use trends
  • 6.2 Hospitals
    • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3 Ambulatory surgical centers
    • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.4 Others
    • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Defibrillators Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Poland
    • 7.3.7 The Netherlands
    • 7.3.8 Sweden
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Indonesia
    • 7.4.7 Thailand
    • 7.4.8 Malaysia
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Chile
    • 7.5.5 Columbia
    • 7.5.6 Peru
  • 7.6 MEA
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Israel
    • 7.6.5 Iran
    • 7.6.6 Turkey

Chapter 8 Company Profiles

  • 8.1 Abbott Laboratories, Inc.
  • 8.2 AMI Italia
  • 8.3 BIOTRONIK SE & Co. KG
  • 8.4 Boston Scientific Corporation
  • 8.5 CU Medical Systems Co. Ltd
  • 8.6 Koninkilijke Philips N.V.
  • 8.7 Medtronic plc
  • 8.8 Meditech Equipment Co., Ltd (Meditech Group)
  • 8.9 MicroPort Scientific Corporation
  • 8.10 Mindray Medical International Limited
  • 8.11 Nihon Kohden Corporation
  • 8.12 BPL Medical Technologies Pvt Ltd
  • 8.13 Schiller AG
  • 8.14 Stryker Corporation
  • 8.15 ZOLL Medical Corporation (Asahi Kasei Group)